• Analysis of SARS-CoV-2 infected samples

    • Read time: 2 minutes

    The Olink Analysis Service labs in Uppsala and Boston are now able to receive SARS-CoV-2 infected samples, regardless of sample type, and process them without inactivation.

    This decision has been made based on the review of US and Sweden governmental regulations and scientific literature, as well as a thorough review of our processes and safety precautions in our labs.

    COVID-19-thumbnail

    At Olink, we are taking every precaution for the well-being of its employees and to ensure that our products and Analysis Service departments are working effectively to continue to support the research community and its vital work.

    Learn more

    Please note that some of our external service providers may still have restrictions on the samples they are accepting and may require pre-treatment of infected samples. If inactivation of your samples is needed, Olink recommends the Triton X-100 protocol.

    Download the recommended TritonX-100 inactivation protocol for Olink studies

    Additional news

    All news
    image for PR

    Press Release: Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease

    HT-banner-hero

    Press Release: Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics